Palmitic Acid

Palmitic Acid

SCHEMBL5886483

CCCCCCCCCCCCCCCC(=O)O.Cc1cc(=O)oc2cc(O)ccc12

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.66
KDM4E B2RXH2 10/20 0.66
HPGD P15428 8/20 0.66
HSD17B10 Q99714 6/20 0.66
HSD17B3 P37058 6/20 0.66
GAA P10253 5/20 0.66
GLA P06280 5/20 0.66
CASP1 P29466 3/20 0.66
CASP7 P55210 3/20 0.66
AKR1B1 P15121 2/20 0.66
CA12 O43570 1/20 0.66
LMNA P02545 1/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2C9 P11712 1/20 0.66
UGT1A1 P22309 1/20 0.66
MAOB P27338 1/20 0.66
KDR P35968 1/20 0.66
MCL1 Q07820 1/20 0.66
CA9 Q16790 1/20 0.66
KMT2A Q03164 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hymecromone SCHEMBL28215495 1.00 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Stearic Acid SCHEMBL28308815 1.00 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Oleic Acid SCHEMBL7041165 0.93 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Oleic Acid SCHEMBL28807513 0.93 ALDH1A1 (0.57) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL5356260 0.91 ALDH1A1 (0.75) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL7594956 0.81 KDM4E (0.87) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL2357040 0.81 HSD17B3 (1.00) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL29364837 0.81 HSD17B3 (1.00) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL29624431 0.81 HSD17B3 (1.00) ALDH1A1KDM4EHPGDHSD17B10HSD17B3
Hymecromone SCHEMBL24150 0.81 HSD17B3 (1.00) ALDH1A1KDM4EHPGDHSD17B10HSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227752-B Enhanced, rapid, homogeneous cell staining and assay 上海宜晟生物科技有限公司 2025-04-29 CN claimed
CN-113260860-B Cellular analysis of body fluids, particularly blood 上海宜晟生物科技有限公司 2025-06-13 CN disclosed
CN-113227752-B Enhanced, rapid, homogeneous cell staining and assay 上海宜晟生物科技有限公司 2025-04-29 CN disclosed
CN-113260458-B Assay using sample thickness multiplexing ESSENLIX 公司 2023-10-27 CN disclosed
CN-116194158-A Biological indicator comprising genetically modified test microorganism 3M创新有限公司 2023-05-30 CN disclosed
CN-115461468-A Biological indicator with test microorganisms encapsulated by wax composition 3M创新有限公司 2022-12-09 CN disclosed
CN-115315522-A Fixed pH indicator for biological indicator growth indication 3M创新有限公司 2022-11-08 CN disclosed
EP-3360576-B1 O/W TYPE EMULSION NOF CORP (JP) 2022-09-28 EP disclosed
CN-114981399-A Self-contained biological indicator with salt compound 3M创新有限公司 2022-08-30 CN disclosed
CN-109985267-B Self-contained biological indicator 伊西康公司 2022-08-05 CN disclosed
US-6991914-B2 Silent marker for an oil product and associated detection method SK CORPORATION (KR) 2006-01-31 US disclosed
EP-1478760-A4 ESTERASES WITH LIPASE ACTIVITY COMMW SCIENT IND RES ORG (AU) 2005-12-28 EP disclosed
EP-1478760-A1 ESTERASES WITH LIPASE ACTIVITY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2004-11-24 EP disclosed
US-20040092738-A1 Silent mark for oil product and detection method thereto SK ENERGY CO., LTD. (KR) 2004-05-13 US disclosed
EP-1309572-A4 SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO SK CORP (KR) 2004-03-17 EP disclosed
WO-2003066873-A1 ESTERASES WITH LIPASE ACTIVITY COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2003-08-14 WO disclosed
EP-1309572-A1 SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO SK Corporation (KR) 2003-05-14 EP disclosed
WO-2002004431-A1 SILENT MARK FOR OIL PRODUCT AND DETECTION METHOD THERETO SK CORPORATION (KR) 2002-01-17 WO disclosed
US-5980593-A Silent fluorescent petroleum markers MORTON INTERNATIONAL, INC. (US) 1999-11-09 US disclosed
US-4299845-A BACTERICIDES, FUNGICIDES SCHERING CORPORATION (US) 1981-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092738-A1 Silent mark for oil product and detection method thereto NOTUM, SQLE, MSMO1 ALDH1A1 501/4885KDM4E 821/4885HPGD 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.